Progyny, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Progyny, Inc. stock issued during period, value, stock options exercised for the quarter ending 2020-06-30 was -$3.26M, a 11355.17% decline year-over-year.
- Progyny, Inc. stock issued during period, value, stock options exercised for the quarter ending 2020-03-31 was $597.00K, a 29750.00% increase year-over-year.
- Progyny, Inc. stock issued during period, value, stock options exercised for the quarter ending 2019-12-31 was $1.53M, a 7947.37% increase year-over-year.
- Progyny, Inc. stock issued during period, value, stock options exercised for the quarter ending 2019-09-30 was $4.98M, a 12658.97% increase year-over-year.
- Progyny, Inc. stock issued during period, value, stock options exercised for fiscal 2019 was $6.54M, a 9955.38% increase from fiscal 2018.
- Progyny, Inc. stock issued during period, value, stock options exercised for fiscal 2018 was $65.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2020-06-30 | -$3.26M 10-Q · filed 2020-08-07 | $3.84M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $597.00K 10-Q · filed 2020-05-14 | $7.13M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $6.54M 10-K · filed 2022-03-01 |
| 2019-09-30 | $4.98M 10-Q · filed 2019-12-06 | $5.03M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $29.00K 10-Q · filed 2020-08-07 | $89.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $2.00K 10-Q · filed 2020-05-14 | |
| 2018-12-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $65.00K 10-K · filed 2021-03-01 |
| 2018-09-30 | $39.00K 10-Q · filed 2019-12-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |